Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Prognostic significance of ischemia episodes in patients with previous myocardial infarction.Am J Cardiol. 1988; 62: 661-664
- Transient ST-segment depression as a marker of myocardial ischemia during daily life.Am J Cardiol. 1984; 54: 1195-1200
- Myocardial ischaemia in patients with frequent angina pectoris.Br Med J. 1978; 2: 1594-1596
- Silent myocardial ischemia: classification, prevalence and prognosis.Am J Med. 1985; 79: 3-6
- Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease.Circulation. 1988; 78: 877-885
- Silent ischemia predicts infarction and death during 2-year follow-up of unstable angina.J Am Coll Cardiol. 1987; 10: 756-760
- Silent ischemia as a marker of early unfavorable outcome in patients with unstable angina.N Engl J Med. 1986; 314: 1214-1219
- Increased mortality in men with ST-segment depression during 24-hour ambulatory long-term ECG recording.Eur Heart J. 1989; 10: 149-158
- Myocardial ischaemia during daily life in patients with stable angina; its relation to symptoms and heart rate changes.Lancet. 1983; 2: 753-758
- Infuence of ischemic heart disease on early and late mortality after surgery for peripheral occlusive vascular disease.Circulation. 1982; 66: I92-I97
- Correlation between preoperative ambulatory ischemia and major cardiac events after peripheral vascular surgery.N Engl J Med. 1989; 321: 1296-1300
- Multifactorial index for cardiac risk in non cardiac surgical procedures.N Engl J Med. 1977; 297: 845-850
- Sudden death in the Framingham heart study: differences in incidence and risk factors by sex and coronary disease status.Am J Epidemiol. 1984; 120: 888-899
- Regression and life tables.J R Statist Soc (B). 1972; 34: 187-220
☆This study was supported in part by the W.K. Kellogg Foundation, Battle Creek, Michigan, Program for Training in Research in Clinical Effectiveness, the American Heart Association, Massachusetts affiliate, Needham, Massachusetts, and by the National Institutes of Health, Bethesda, Maryland (Grant RO 1 HL 35295).